A carregar...
Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
Sunitinib, a multitargeted tyrosine-kinase inhibitor, extends survival of patients with metastatic renal cell carcinoma (mRCC) and gastrointestinal stromal tumours. Between October 2005 and March 2007, we retrospectively reviewed blood glucose level variations associated with sunitinib therapy in pa...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2579676/ https://ncbi.nlm.nih.gov/pubmed/18841151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604709 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|